Nephrada · FSGS · United Kingdom · Academic nephrologist · captured by Dr. Anna Becker on 01 Aug 2026 · reviewed by Dr. Elena Moretti on 06 Aug 2026
Verbatim as captured; never edited
Academic nephrologist at Guy's and St Thomas' raised egfr slope interpretation during a scientific exchange. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Elena Moretti on 06 Aug 2026
eGFR slope interpretation: interest in collaboration reported by academic nephrologist (GB).
helixor-private-llm-2026.05 · generated 01 Aug 2026, 10:00 UTC
AI summary
eGFR slope interpretation raised by academic nephrologist; relevant for Clinical Development.
Source spans used by the model
Academic nephrologist at Guy's and St Thomas' raised egfr slope interpretation during a scientific exchange. They requested supporting literature and a follow-up discussion.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Unmet medical need | Unmet medical need |
| Function | Clinical Development | Clinical Development |
| Priority | Critical | Critical |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 5 | 20% | 20.0 |
| Scientific importance | 4 | 15% | 12.0 |
| Urgency | 3 | 15% | 9.0 |
| Novelty | 3 | 10% | 6.0 |
| Actionability | 5 | 10% | 10.0 |
| Confidence | 2 | 5% | 2.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | Critical 79 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
01 Aug 2026 · Dr. Yuki Meyer, Guy's and St Thomas' · MSL Dr. Anna Becker
Insight
Reviewed 06 Aug 2026 by Dr. Elena Moretti
Action
Medical education program · Dr. Anna Becker · In progress
Decision
Outcome
Closure
Addressed in scientific platform update.